Basic Information
Exviera
Regulatory Information
EMEA/H/C/003837
January 14, 2015
November 20, 2004
26
April 13, 2023
Company Information
United Kingdom
Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4UB
ABBVIE LTD
Drug Classification
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Exviera is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults. For hepatitis C virus (HCV) genotype specific activity.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Exviera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Exviera. For practical information about using Exviera, patients should read the package leaflet or contact their doctor or pharmacist.